Story
Salesforce Earnings Preview: Investors Watch Guidance as Stock Lags Despite Beat Streak

Salesforce (NYSE: CRM) is scheduled to report its fiscal second-quarter 2027 earnings after the market closes, placing the software giant in a critical "prove it" moment with investors. Despite a consistent track record of surpassing earnings estimates, the company's stock has fallen 22% year-to-date and sits 24% below its 52-week high.
History of Unrewarded Beats
Salesforce has exceeded Wall Street's earnings per share (EPS) expectations for four consecutive quarters, with an average surprise of +17%, according to Investing.com data. However, this performance has not consistently translated into stock gains. Following last quarter's +24% EPS surprise, the stock fell 1.6%, signaling that investors are now focused on future growth prospects rather than past results.
For the upcoming report, market consensus anticipates an EPS of $3.27 on revenue of $11.33 billion. The key metric for investors will be the company's forward guidance, particularly signs of reacceleration in revenue growth and updates on its AI monetization strategy.
Valuation Disconnect
The company's current valuation metrics suggest the market is pricing in a slowdown. Salesforce trades at a forward price-to-earnings (P/E) ratio of 14.2x and a price/earnings-to-growth (PEG) ratio of 0.60, figures that are low compared to many enterprise software peers and the company's own historical averages. This valuation has attracted bullish analyst sentiment, with JPMorgan initiating coverage at Overweight with a $250 price target and Truist maintaining a Buy rating with a $280 target.
AdKey valuation and performance metrics include:
- Forward P/E: 14.2x
- PEG Ratio: 0.60 (a value below 1.0 often suggests a stock may be undervalued relative to its growth prospects)
- Free Cash Flow Yield: 8.7%
- Analyst Consensus: 39 Buy, 12 Hold, 2 Sell ratings
Key Factors and Market Outlook
Investors are weighing a compelling bull case against persistent headwinds. Bullish arguments center on the potential for growth reacceleration, driven by AI product monetization, major government contracts, and expanding profit margins, which reached 77.7% on a gross basis. An inflection in net-new Annual Order Value (AOV) growth is seen as a leading indicator for future revenue.
Conversely, bears point to the stock's poor performance despite strong earnings, the risk of a "sell-the-news" reaction, and concerns over decelerating revenue growth, which stands at 11%. Technically, the stock is approaching resistance after a 25.6% rally in the past month, with weekly indicators suggesting it is in overbought territory. A guidance miss could see the stock test support levels around $195.69 and $182.22, while a strong outlook could help it break through resistance near $216.85.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.